These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 24083782)
21. Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains. Nikolovska-Coleska Z; Meagher JL; Jiang S; Kawamoto SA; Gao W; Yi H; Qin D; Roller PP; Stuckey JA; Wang S Anal Biochem; 2008 Mar; 374(1):87-98. PubMed ID: 18023397 [TBL] [Abstract][Full Text] [Related]
22. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles. Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976 [TBL] [Abstract][Full Text] [Related]
24. Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP). Tamanini E; Buck IM; Chessari G; Chiarparin E; Day JEH; Frederickson M; Griffiths-Jones CM; Hearn K; Heightman TD; Iqbal A; Johnson CN; Lewis EJ; Martins V; Peakman T; Reader M; Rich SJ; Ward GA; Williams PA; Wilsher NE J Med Chem; 2017 Jun; 60(11):4611-4625. PubMed ID: 28492317 [TBL] [Abstract][Full Text] [Related]
25. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein. Nikolovska-Coleska Z; Meagher JL; Jiang S; Yang CY; Qiu S; Roller PP; Stuckey JA; Wang S Biochemistry; 2008 Sep; 47(37):9811-24. PubMed ID: 18717598 [TBL] [Abstract][Full Text] [Related]
26. Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP. Chessari G; Buck IM; Day JE; Day PJ; Iqbal A; Johnson CN; Lewis EJ; Martins V; Miller D; Reader M; Rees DC; Rich SJ; Tamanini E; Vitorino M; Ward GA; Williams PA; Williams G; Wilsher NE; Woolford AJ J Med Chem; 2015 Aug; 58(16):6574-88. PubMed ID: 26218264 [TBL] [Abstract][Full Text] [Related]
27. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac. Huang Y; Rich RL; Myszka DG; Wu H J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414 [TBL] [Abstract][Full Text] [Related]
28. Targeting XIAP for the treatment of malignancy. Schimmer AD; Dalili S; Batey RA; Riedl SJ Cell Death Differ; 2006 Feb; 13(2):179-88. PubMed ID: 16322751 [TBL] [Abstract][Full Text] [Related]
29. ARTS binds to a distinct domain in XIAP-BIR3 and promotes apoptosis by a mechanism that is different from other IAP-antagonists. Bornstein B; Gottfried Y; Edison N; Shekhtman A; Lev T; Glaser F; Larisch S Apoptosis; 2011 Sep; 16(9):869-81. PubMed ID: 21695558 [TBL] [Abstract][Full Text] [Related]
31. WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway. Ding R; Wang X; Chen W; Li Z; Wei AL; Wang QB; Nie AH; Wang LL Acta Pharmacol Sin; 2019 Nov; 40(11):1466-1479. PubMed ID: 31316176 [TBL] [Abstract][Full Text] [Related]
32. IAP family of cell death and signaling regulators. Silke J; Vucic D Methods Enzymol; 2014; 545():35-65. PubMed ID: 25065885 [TBL] [Abstract][Full Text] [Related]
33. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists. Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850 [TBL] [Abstract][Full Text] [Related]
34. Copper-binding properties of the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein. Liang Y; Ewing PM; Laursen WJ; Tripp VT; Singh S; Splan KE J Inorg Biochem; 2014 Nov; 140():104-10. PubMed ID: 25105866 [TBL] [Abstract][Full Text] [Related]
35. BIR2 domain of XIAP plays a marginal role in inhibition of executioner caspases. Abhari BA; Davoodi J Int J Biol Macromol; 2010 Apr; 46(3):337-41. PubMed ID: 20060411 [TBL] [Abstract][Full Text] [Related]
36. Design of small-molecule Smac mimetics as IAP antagonists. Wang S Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626 [TBL] [Abstract][Full Text] [Related]
37. Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic. Balakrishnan K; Fu M; Onida F; Wierda WG; Keating MJ; Gandhi V Oncotarget; 2016 Jun; 7(26):39458-39472. PubMed ID: 27223062 [TBL] [Abstract][Full Text] [Related]
38. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. Oost TK; Sun C; Armstrong RC; Al-Assaad AS; Betz SF; Deckwerth TL; Ding H; Elmore SW; Meadows RP; Olejniczak ET; Oleksijew A; Oltersdorf T; Rosenberg SH; Shoemaker AR; Tomaselli KJ; Zou H; Fesik SW J Med Chem; 2004 Aug; 47(18):4417-26. PubMed ID: 15317454 [TBL] [Abstract][Full Text] [Related]
39. Cyclopeptide Smac mimetics as antagonists of IAP proteins. Sun H; Liu L; Lu J; Qiu S; Yang CY; Yi H; Wang S Bioorg Med Chem Lett; 2010 May; 20(10):3043-6. PubMed ID: 20443226 [TBL] [Abstract][Full Text] [Related]
40. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]